We are live on ! Find out more
APEN

Apollo Endosurgery, Inc.

Delisted

APEN was delisted on the 3rd of April, 2023.

13 hedge funds and large institutions have $10.7M invested in Apollo Endosurgery, Inc. in 2013 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 1

32% more capital invested

Capital invested by funds: $8.12M → $10.7M (+$2.62M)

13% less funds holding

Funds holding: 1513 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $56K

Holders
13
Holders Change
-2
Holders Change %
-13.33%
% of All Funds
0.42%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
8
Reduced
1
Closed
3
Calls
Puts
$56K
Net Calls
-$56K
Net Calls Change
-$56K

APEN Hedge Fund Activity: Q3 2013 in Review

13 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q3 2013, worth a combined $10.7M — up 32% from $8.12M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of APEN and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 8 added.

The largest buyer was Franklin Resources, adding an estimated $1.31M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $880K sold.

  • 13 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q3 2013, down from 15 in Q2 2013.
  • Funds reported $10.7M of Apollo Endosurgery, Inc. stock for Q3 2013, up 32% quarter-over-quarter.
  • 1 fund opened new Apollo Endosurgery, Inc. positions in Q3 2013 and 3 closed out, a net change of -2 holders.
  • The largest Apollo Endosurgery, Inc. buyer in Q3 2013 was Franklin Resources, an estimated $1.31M added.
  • The largest Apollo Endosurgery, Inc. seller in Q3 2013 was Baker Bros. Advisors, an estimated $880K sold.

Based on aggregated 13F filings for Q3 2013.